71 MET immunoreactivity and poor prognosis Supplementary table S4: Anticipated MET protein products and C-terminal fragments. Products and fragments Description Used abbreviations Figure 1B, Supplementary figures 1A & 1B References p170MET Single chain MET precursor p170 (3) p145MET MET full-length β-subunit p145 (3) p95MET Possible C-terminal fragment resulting after ectodomain shedding p95 (5) p90MET Possible C-terminal fragment resulting after ectodomain shedding p90 (5) p70MET Possible C-terminal fragment resulting after ectodomain shedding p70 (3, 5) p60MET Possible C-terminal fragment resulting after ectodomain shedding p60 (3, 5) p55MET Membrane-anchored C-terminal fragment p55 (6) p50MET Intracellular domain of MET p50 (1) p45MET Possible C-terminal fragment resulting after ectodomain shedding p45 (5) p40MET Proapoptotic intracellular 40 kDa C-terminal fragment p40 (7, 8) 3
RkJQdWJsaXNoZXIy MTk4NDMw